nodes	percent_of_prediction	percent_of_DWPC	metapath
Esmolol—hypertension—obesity	0.383	1	CtDrD
Esmolol—ADRB1—obesity	0.133	0.543	CbGaD
Esmolol—ADRB2—obesity	0.112	0.457	CbGaD
Esmolol—Propafenone—Benzphetamine—obesity	0.0979	1	CrCrCtD
Esmolol—ADRB2—Phenylpropanolamine—obesity	0.0921	0.504	CbGbCtD
Esmolol—ADRB1—Phenylpropanolamine—obesity	0.0907	0.496	CbGbCtD
Esmolol—Ibuprofen—FABP2—obesity	0.000236	0.0825	CrCbGaD
Esmolol—Constipation—Phenylpropanolamine—obesity	0.000208	0.00364	CcSEcCtD
Esmolol—Dizziness—Benzphetamine—obesity	0.000207	0.00361	CcSEcCtD
Esmolol—Dry mouth—Diethylpropion—obesity	0.000207	0.00361	CcSEcCtD
Esmolol—Dyspepsia—Phentermine—obesity	0.000205	0.00358	CcSEcCtD
Esmolol—Headache—Methamphetamine—obesity	0.000203	0.00355	CcSEcCtD
Esmolol—Gastrointestinal disorder—Phentermine—obesity	0.000201	0.00352	CcSEcCtD
Esmolol—Fatigue—Phentermine—obesity	0.000201	0.00351	CcSEcCtD
Esmolol—Nasal congestion—Bupropion—obesity	0.000201	0.00351	CcSEcCtD
Esmolol—Feeling abnormal—Phenylpropanolamine—obesity	0.000201	0.00351	CcSEcCtD
Esmolol—Anxiety—Cimetidine—obesity	0.000201	0.0035	CcSEcCtD
Esmolol—Cardiac arrest—Sibutramine—obesity	0.0002	0.00348	CcSEcCtD
Esmolol—Urinary retention—Sibutramine—obesity	0.0002	0.00348	CcSEcCtD
Esmolol—Constipation—Phentermine—obesity	0.000199	0.00348	CcSEcCtD
Esmolol—Rigors—Topiramate—obesity	0.000197	0.00343	CcSEcCtD
Esmolol—Hyperhidrosis—Diethylpropion—obesity	0.000196	0.00342	CcSEcCtD
Esmolol—Headache—Benzphetamine—obesity	0.000196	0.00342	CcSEcCtD
Esmolol—Confusional state—Cimetidine—obesity	0.000195	0.0034	CcSEcCtD
Esmolol—Pallor—Topiramate—obesity	0.000194	0.00338	CcSEcCtD
Esmolol—Dizziness—Phendimetrazine—obesity	0.000189	0.00329	CcSEcCtD
Esmolol—Speech disorder—Topiramate—obesity	0.000187	0.00326	CcSEcCtD
Esmolol—Nausea—Benzphetamine—obesity	0.000186	0.00325	CcSEcCtD
Esmolol—Urticaria—Phentermine—obesity	0.000185	0.00324	CcSEcCtD
Esmolol—Bronchospasm—Orlistat—obesity	0.000184	0.00322	CcSEcCtD
Esmolol—Sweating increased—Orlistat—obesity	0.000183	0.00319	CcSEcCtD
Esmolol—Dyspnoea—Diethylpropion—obesity	0.000181	0.00316	CcSEcCtD
Esmolol—Somnolence—Diethylpropion—obesity	0.00018	0.00315	CcSEcCtD
Esmolol—Abdominal discomfort—Orlistat—obesity	0.00018	0.00314	CcSEcCtD
Esmolol—Headache—Phendimetrazine—obesity	0.000179	0.00312	CcSEcCtD
Esmolol—Dyspepsia—Diethylpropion—obesity	0.000179	0.00312	CcSEcCtD
Esmolol—Skin discolouration—Topiramate—obesity	0.000178	0.0031	CcSEcCtD
Esmolol—Angina pectoris—Sibutramine—obesity	0.000177	0.00309	CcSEcCtD
Esmolol—Thinking abnormal—Topiramate—obesity	0.000175	0.00306	CcSEcCtD
Esmolol—Gastrointestinal disorder—Diethylpropion—obesity	0.000175	0.00306	CcSEcCtD
Esmolol—Irritability—Bupropion—obesity	0.000175	0.00305	CcSEcCtD
Esmolol—Oliguria—Topiramate—obesity	0.000174	0.00304	CcSEcCtD
Esmolol—Urinary retention—Bupropion—obesity	0.000174	0.00304	CcSEcCtD
Esmolol—Constipation—Diethylpropion—obesity	0.000173	0.00303	CcSEcCtD
Esmolol—Somnolence—Cimetidine—obesity	0.000172	0.003	CcSEcCtD
Esmolol—Dysuria—Sibutramine—obesity	0.00017	0.00296	CcSEcCtD
Esmolol—Nausea—Phendimetrazine—obesity	0.000169	0.00296	CcSEcCtD
Esmolol—Asthenia—Phentermine—obesity	0.000167	0.00292	CcSEcCtD
Esmolol—Feeling abnormal—Diethylpropion—obesity	0.000167	0.00292	CcSEcCtD
Esmolol—Fatigue—Cimetidine—obesity	0.000166	0.00291	CcSEcCtD
Esmolol—Atrioventricular block—Topiramate—obesity	0.000166	0.00289	CcSEcCtD
Esmolol—Constipation—Cimetidine—obesity	0.000165	0.00288	CcSEcCtD
Esmolol—Neuropathy peripheral—Orlistat—obesity	0.000164	0.00286	CcSEcCtD
Esmolol—Nasopharyngitis—Bupropion—obesity	0.000164	0.00286	CcSEcCtD
Esmolol—Urticaria—Diethylpropion—obesity	0.000161	0.00281	CcSEcCtD
Esmolol—Dizziness—Phenylpropanolamine—obesity	0.000161	0.00281	CcSEcCtD
Esmolol—Acute coronary syndrome—Sibutramine—obesity	0.000159	0.00278	CcSEcCtD
Esmolol—Feeling abnormal—Cimetidine—obesity	0.000159	0.00278	CcSEcCtD
Esmolol—Neuropathy peripheral—Sibutramine—obesity	0.000159	0.00277	CcSEcCtD
Esmolol—Myocardial infarction—Sibutramine—obesity	0.000159	0.00277	CcSEcCtD
Esmolol—Bronchospasm—Bupropion—obesity	0.000156	0.00272	CcSEcCtD
Esmolol—Vomiting—Phenylpropanolamine—obesity	0.000155	0.00271	CcSEcCtD
Esmolol—Dizziness—Phentermine—obesity	0.000154	0.00269	CcSEcCtD
Esmolol—Sweating increased—Bupropion—obesity	0.000154	0.00269	CcSEcCtD
Esmolol—Body temperature increased—Cimetidine—obesity	0.000153	0.00266	CcSEcCtD
Esmolol—Abdominal discomfort—Bupropion—obesity	0.000152	0.00265	CcSEcCtD
Esmolol—Neuropathy—Topiramate—obesity	0.000151	0.00263	CcSEcCtD
Esmolol—Pharyngitis—Orlistat—obesity	0.000149	0.0026	CcSEcCtD
Esmolol—Vomiting—Phentermine—obesity	0.000148	0.00259	CcSEcCtD
Esmolol—Urinary tract disorder—Orlistat—obesity	0.000148	0.00259	CcSEcCtD
Esmolol—Dysuria—Bupropion—obesity	0.000148	0.00258	CcSEcCtD
Esmolol—Bradycardia—Sibutramine—obesity	0.000148	0.00258	CcSEcCtD
Esmolol—Urethral disorder—Orlistat—obesity	0.000147	0.00257	CcSEcCtD
Esmolol—Headache—Phentermine—obesity	0.000146	0.00255	CcSEcCtD
Esmolol—Rhinitis—Sibutramine—obesity	0.000146	0.00254	CcSEcCtD
Esmolol—Nausea—Phenylpropanolamine—obesity	0.000145	0.00253	CcSEcCtD
Esmolol—Pharyngitis—Sibutramine—obesity	0.000144	0.00252	CcSEcCtD
Esmolol—Alprenolol—ADRB3—obesity	0.000143	0.0499	CrCbGaD
Esmolol—Abnormal vision—Topiramate—obesity	0.00014	0.00245	CcSEcCtD
Esmolol—Visual impairment—Sibutramine—obesity	0.00014	0.00244	CcSEcCtD
Esmolol—Mental disability—Topiramate—obesity	0.000139	0.00243	CcSEcCtD
Esmolol—Acute coronary syndrome—Bupropion—obesity	0.000139	0.00243	CcSEcCtD
Esmolol—Nausea—Phentermine—obesity	0.000139	0.00242	CcSEcCtD
Esmolol—Asthenia—Cimetidine—obesity	0.000138	0.00242	CcSEcCtD
Esmolol—Neuropathy peripheral—Bupropion—obesity	0.000138	0.00241	CcSEcCtD
Esmolol—Myocardial infarction—Bupropion—obesity	0.000138	0.00241	CcSEcCtD
Esmolol—Dizziness—Diethylpropion—obesity	0.000134	0.00234	CcSEcCtD
Esmolol—Angiopathy—Sibutramine—obesity	0.000132	0.0023	CcSEcCtD
Esmolol—Mental disorder—Orlistat—obesity	0.000131	0.00229	CcSEcCtD
Esmolol—Chills—Sibutramine—obesity	0.00013	0.00227	CcSEcCtD
Esmolol—Vomiting—Diethylpropion—obesity	0.000129	0.00225	CcSEcCtD
Esmolol—Nasal congestion—Topiramate—obesity	0.000128	0.00223	CcSEcCtD
Esmolol—Dysgeusia—Orlistat—obesity	0.000128	0.00223	CcSEcCtD
Esmolol—Dizziness—Cimetidine—obesity	0.000128	0.00223	CcSEcCtD
Esmolol—Headache—Diethylpropion—obesity	0.000127	0.00222	CcSEcCtD
Esmolol—Rhinitis—Bupropion—obesity	0.000127	0.00222	CcSEcCtD
Esmolol—Pharyngitis—Bupropion—obesity	0.000126	0.00219	CcSEcCtD
Esmolol—Urinary tract disorder—Bupropion—obesity	0.000125	0.00218	CcSEcCtD
Esmolol—Urethral disorder—Bupropion—obesity	0.000124	0.00217	CcSEcCtD
Esmolol—Dysgeusia—Sibutramine—obesity	0.000124	0.00216	CcSEcCtD
Esmolol—Vomiting—Cimetidine—obesity	0.000123	0.00214	CcSEcCtD
Esmolol—Practolol—ADRB1—obesity	0.000123	0.0429	CrCbGaD
Esmolol—Pindolol—ADRB3—obesity	0.000123	0.0429	CrCbGaD
Esmolol—Visual impairment—Bupropion—obesity	0.000122	0.00213	CcSEcCtD
Esmolol—Headache—Cimetidine—obesity	0.000121	0.00211	CcSEcCtD
Esmolol—Nausea—Diethylpropion—obesity	0.00012	0.0021	CcSEcCtD
Esmolol—Angioedema—Orlistat—obesity	0.000119	0.00208	CcSEcCtD
Esmolol—Flushing—Bupropion—obesity	0.000117	0.00205	CcSEcCtD
Esmolol—Cardiac disorder—Bupropion—obesity	0.000117	0.00205	CcSEcCtD
Esmolol—Agitation—Sibutramine—obesity	0.000116	0.00203	CcSEcCtD
Esmolol—Angioedema—Sibutramine—obesity	0.000115	0.00202	CcSEcCtD
Esmolol—Angiopathy—Bupropion—obesity	0.000115	0.00201	CcSEcCtD
Esmolol—Nausea—Cimetidine—obesity	0.000115	0.002	CcSEcCtD
Esmolol—Chills—Bupropion—obesity	0.000114	0.00198	CcSEcCtD
Esmolol—Syncope—Sibutramine—obesity	0.000113	0.00198	CcSEcCtD
Esmolol—Convulsion—Orlistat—obesity	0.000113	0.00198	CcSEcCtD
Esmolol—Irritability—Topiramate—obesity	0.000111	0.00194	CcSEcCtD
Esmolol—Chest pain—Orlistat—obesity	0.000111	0.00194	CcSEcCtD
Esmolol—Loss of consciousness—Sibutramine—obesity	0.000111	0.00194	CcSEcCtD
Esmolol—Metipranolol—ADRB1—obesity	0.000111	0.0388	CrCbGaD
Esmolol—Mental disorder—Bupropion—obesity	0.000111	0.00194	CcSEcCtD
Esmolol—Urinary retention—Topiramate—obesity	0.000111	0.00194	CcSEcCtD
Esmolol—Anxiety—Orlistat—obesity	0.000111	0.00193	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.00011	0.00193	CcSEcCtD
Esmolol—Convulsion—Sibutramine—obesity	0.000109	0.00191	CcSEcCtD
Esmolol—Dry mouth—Orlistat—obesity	0.000109	0.0019	CcSEcCtD
Esmolol—Dysgeusia—Bupropion—obesity	0.000108	0.00188	CcSEcCtD
Esmolol—Chest pain—Sibutramine—obesity	0.000108	0.00188	CcSEcCtD
Esmolol—Anxiety—Sibutramine—obesity	0.000107	0.00187	CcSEcCtD
Esmolol—Oedema—Orlistat—obesity	0.000107	0.00186	CcSEcCtD
Esmolol—Dry mouth—Sibutramine—obesity	0.000105	0.00184	CcSEcCtD
Esmolol—Nervous system disorder—Orlistat—obesity	0.000105	0.00183	CcSEcCtD
Esmolol—Nasopharyngitis—Topiramate—obesity	0.000104	0.00182	CcSEcCtD
Esmolol—Confusional state—Sibutramine—obesity	0.000104	0.00182	CcSEcCtD
Esmolol—Skin disorder—Orlistat—obesity	0.000104	0.00181	CcSEcCtD
Esmolol—Oedema—Sibutramine—obesity	0.000103	0.0018	CcSEcCtD
Esmolol—Hyperhidrosis—Orlistat—obesity	0.000103	0.0018	CcSEcCtD
Esmolol—Shock—Sibutramine—obesity	0.000101	0.00177	CcSEcCtD
Esmolol—Agitation—Bupropion—obesity	0.000101	0.00177	CcSEcCtD
Esmolol—Angioedema—Bupropion—obesity	0.000101	0.00176	CcSEcCtD
Esmolol—Skin disorder—Sibutramine—obesity	0.0001	0.00175	CcSEcCtD
Esmolol—Hyperhidrosis—Sibutramine—obesity	9.97e-05	0.00174	CcSEcCtD
Esmolol—Sotalol—ADRB1—obesity	9.89e-05	0.0346	CrCbGaD
Esmolol—Syncope—Bupropion—obesity	9.88e-05	0.00173	CcSEcCtD
Esmolol—Anorexia—Sibutramine—obesity	9.83e-05	0.00172	CcSEcCtD
Esmolol—Sweating increased—Topiramate—obesity	9.81e-05	0.00171	CcSEcCtD
Esmolol—Angina pectoris—Topiramate—obesity	9.81e-05	0.00171	CcSEcCtD
Esmolol—Loss of consciousness—Bupropion—obesity	9.68e-05	0.00169	CcSEcCtD
Esmolol—Abdominal discomfort—Topiramate—obesity	9.66e-05	0.00169	CcSEcCtD
Esmolol—Hypotension—Sibutramine—obesity	9.64e-05	0.00168	CcSEcCtD
Esmolol—Paraesthesia—Orlistat—obesity	9.57e-05	0.00167	CcSEcCtD
Esmolol—Convulsion—Bupropion—obesity	9.54e-05	0.00167	CcSEcCtD
Esmolol—Dysuria—Topiramate—obesity	9.42e-05	0.00164	CcSEcCtD
Esmolol—Dyspepsia—Orlistat—obesity	9.38e-05	0.00164	CcSEcCtD
Esmolol—Chest pain—Bupropion—obesity	9.38e-05	0.00164	CcSEcCtD
Esmolol—Acebutolol—SLC22A1—obesity	9.35e-05	0.0327	CrCbGaD
Esmolol—Anxiety—Bupropion—obesity	9.35e-05	0.00163	CcSEcCtD
Esmolol—Metipranolol—ADRB2—obesity	9.33e-05	0.0326	CrCbGaD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	9.31e-05	0.00163	CcSEcCtD
Esmolol—Decreased appetite—Orlistat—obesity	9.26e-05	0.00162	CcSEcCtD
Esmolol—Paraesthesia—Sibutramine—obesity	9.26e-05	0.00162	CcSEcCtD
Esmolol—Gastrointestinal disorder—Orlistat—obesity	9.2e-05	0.00161	CcSEcCtD
Esmolol—Dyspnoea—Sibutramine—obesity	9.19e-05	0.00161	CcSEcCtD
Esmolol—Fatigue—Orlistat—obesity	9.19e-05	0.0016	CcSEcCtD
Esmolol—Dry mouth—Bupropion—obesity	9.17e-05	0.0016	CcSEcCtD
Esmolol—Somnolence—Sibutramine—obesity	9.17e-05	0.0016	CcSEcCtD
Esmolol—Pain—Orlistat—obesity	9.11e-05	0.00159	CcSEcCtD
Esmolol—Dyspepsia—Sibutramine—obesity	9.08e-05	0.00159	CcSEcCtD
Esmolol—Confusional state—Bupropion—obesity	9.07e-05	0.00158	CcSEcCtD
Esmolol—Oedema—Bupropion—obesity	8.99e-05	0.00157	CcSEcCtD
Esmolol—Decreased appetite—Sibutramine—obesity	8.97e-05	0.00157	CcSEcCtD
Esmolol—Gastrointestinal disorder—Sibutramine—obesity	8.9e-05	0.00155	CcSEcCtD
Esmolol—Shock—Bupropion—obesity	8.85e-05	0.00154	CcSEcCtD
Esmolol—Pain—Sibutramine—obesity	8.82e-05	0.00154	CcSEcCtD
Esmolol—Constipation—Sibutramine—obesity	8.82e-05	0.00154	CcSEcCtD
Esmolol—Nervous system disorder—Bupropion—obesity	8.82e-05	0.00154	CcSEcCtD
Esmolol—Neuropathy peripheral—Topiramate—obesity	8.8e-05	0.00154	CcSEcCtD
Esmolol—Feeling abnormal—Orlistat—obesity	8.78e-05	0.00153	CcSEcCtD
Esmolol—Skin disorder—Bupropion—obesity	8.73e-05	0.00153	CcSEcCtD
Esmolol—Bevantolol—ADRB1—obesity	8.7e-05	0.0305	CrCbGaD
Esmolol—Hyperhidrosis—Bupropion—obesity	8.69e-05	0.00152	CcSEcCtD
Esmolol—Anorexia—Bupropion—obesity	8.57e-05	0.0015	CcSEcCtD
Esmolol—Feeling abnormal—Sibutramine—obesity	8.5e-05	0.00148	CcSEcCtD
Esmolol—Urticaria—Orlistat—obesity	8.47e-05	0.00148	CcSEcCtD
Esmolol—Body temperature increased—Orlistat—obesity	8.42e-05	0.00147	CcSEcCtD
Esmolol—Hypotension—Bupropion—obesity	8.4e-05	0.00147	CcSEcCtD
Esmolol—Sotalol—ADRB2—obesity	8.32e-05	0.0291	CrCbGaD
Esmolol—Bradycardia—Topiramate—obesity	8.21e-05	0.00143	CcSEcCtD
Esmolol—Urticaria—Sibutramine—obesity	8.19e-05	0.00143	CcSEcCtD
Esmolol—Body temperature increased—Sibutramine—obesity	8.15e-05	0.00142	CcSEcCtD
Esmolol—Rhinitis—Topiramate—obesity	8.08e-05	0.00141	CcSEcCtD
Esmolol—Paraesthesia—Bupropion—obesity	8.07e-05	0.00141	CcSEcCtD
Esmolol—Dyspnoea—Bupropion—obesity	8.02e-05	0.0014	CcSEcCtD
Esmolol—Pharyngitis—Topiramate—obesity	8e-05	0.0014	CcSEcCtD
Esmolol—Somnolence—Bupropion—obesity	7.99e-05	0.0014	CcSEcCtD
Esmolol—Urinary tract disorder—Topiramate—obesity	7.96e-05	0.00139	CcSEcCtD
Esmolol—Dyspepsia—Bupropion—obesity	7.91e-05	0.00138	CcSEcCtD
Esmolol—Urethral disorder—Topiramate—obesity	7.9e-05	0.00138	CcSEcCtD
Esmolol—Decreased appetite—Bupropion—obesity	7.82e-05	0.00136	CcSEcCtD
Esmolol—Visual impairment—Topiramate—obesity	7.77e-05	0.00136	CcSEcCtD
Esmolol—Gastrointestinal disorder—Bupropion—obesity	7.76e-05	0.00136	CcSEcCtD
Esmolol—Betaxolol—ADRB1—obesity	7.76e-05	0.0271	CrCbGaD
Esmolol—Fatigue—Bupropion—obesity	7.75e-05	0.00135	CcSEcCtD
Esmolol—Atenolol—ADRB1—obesity	7.69e-05	0.0269	CrCbGaD
Esmolol—Pain—Bupropion—obesity	7.69e-05	0.00134	CcSEcCtD
Esmolol—Constipation—Bupropion—obesity	7.69e-05	0.00134	CcSEcCtD
Esmolol—Asthenia—Orlistat—obesity	7.65e-05	0.00134	CcSEcCtD
Esmolol—Pruritus—Orlistat—obesity	7.54e-05	0.00132	CcSEcCtD
Esmolol—Chlorphenesin—CYP19A1—obesity	7.54e-05	0.0264	CrCbGaD
Esmolol—Chlorphenesin—BCHE—obesity	7.52e-05	0.0263	CrCbGaD
Esmolol—Bisoprolol—ADRB1—obesity	7.49e-05	0.0262	CrCbGaD
Esmolol—Cardiac disorder—Topiramate—obesity	7.48e-05	0.00131	CcSEcCtD
Esmolol—Flushing—Topiramate—obesity	7.48e-05	0.00131	CcSEcCtD
Esmolol—Feeling abnormal—Bupropion—obesity	7.41e-05	0.00129	CcSEcCtD
Esmolol—Asthenia—Sibutramine—obesity	7.4e-05	0.00129	CcSEcCtD
Esmolol—Bevantolol—ADRB2—obesity	7.32e-05	0.0256	CrCbGaD
Esmolol—Angiopathy—Topiramate—obesity	7.32e-05	0.00128	CcSEcCtD
Esmolol—Pruritus—Sibutramine—obesity	7.3e-05	0.00127	CcSEcCtD
Esmolol—Chills—Topiramate—obesity	7.23e-05	0.00126	CcSEcCtD
Esmolol—Urticaria—Bupropion—obesity	7.14e-05	0.00125	CcSEcCtD
Esmolol—Body temperature increased—Bupropion—obesity	7.11e-05	0.00124	CcSEcCtD
Esmolol—Acebutolol—ADRB1—obesity	7.1e-05	0.0248	CrCbGaD
Esmolol—Mental disorder—Topiramate—obesity	7.06e-05	0.00123	CcSEcCtD
Esmolol—Dizziness—Orlistat—obesity	7.05e-05	0.00123	CcSEcCtD
Esmolol—Oxprenolol—ADRB1—obesity	7.05e-05	0.0246	CrCbGaD
Esmolol—Erythema—Topiramate—obesity	7.02e-05	0.00123	CcSEcCtD
Esmolol—Dysgeusia—Topiramate—obesity	6.87e-05	0.0012	CcSEcCtD
Esmolol—Dizziness—Sibutramine—obesity	6.82e-05	0.00119	CcSEcCtD
Esmolol—Vomiting—Orlistat—obesity	6.78e-05	0.00118	CcSEcCtD
Esmolol—Propranolol—ADRB3—obesity	6.69e-05	0.0234	CrCbGaD
Esmolol—Headache—Orlistat—obesity	6.68e-05	0.00117	CcSEcCtD
Esmolol—Ibuprofen—BCL2—obesity	6.61e-05	0.0231	CrCbGaD
Esmolol—Vomiting—Sibutramine—obesity	6.56e-05	0.00115	CcSEcCtD
Esmolol—Betaxolol—ADRB2—obesity	6.53e-05	0.0228	CrCbGaD
Esmolol—Atenolol—ADRB2—obesity	6.47e-05	0.0226	CrCbGaD
Esmolol—Headache—Sibutramine—obesity	6.46e-05	0.00113	CcSEcCtD
Esmolol—Asthenia—Bupropion—obesity	6.45e-05	0.00113	CcSEcCtD
Esmolol—Agitation—Topiramate—obesity	6.45e-05	0.00113	CcSEcCtD
Esmolol—Alprenolol—ADRB1—obesity	6.44e-05	0.0225	CrCbGaD
Esmolol—Pruritus—Bupropion—obesity	6.36e-05	0.00111	CcSEcCtD
Esmolol—Nausea—Orlistat—obesity	6.33e-05	0.00111	CcSEcCtD
Esmolol—Bisoprolol—ADRB2—obesity	6.3e-05	0.022	CrCbGaD
Esmolol—Syncope—Topiramate—obesity	6.29e-05	0.0011	CcSEcCtD
Esmolol—Pindolol—HTR1B—obesity	6.27e-05	0.0219	CrCbGaD
Esmolol—Loss of consciousness—Topiramate—obesity	6.17e-05	0.00108	CcSEcCtD
Esmolol—Nausea—Sibutramine—obesity	6.13e-05	0.00107	CcSEcCtD
Esmolol—Convulsion—Topiramate—obesity	6.08e-05	0.00106	CcSEcCtD
Esmolol—Metoprolol—ADRB1—obesity	5.99e-05	0.021	CrCbGaD
Esmolol—Chest pain—Topiramate—obesity	5.98e-05	0.00104	CcSEcCtD
Esmolol—Acebutolol—ADRB2—obesity	5.97e-05	0.0209	CrCbGaD
Esmolol—Anxiety—Topiramate—obesity	5.95e-05	0.00104	CcSEcCtD
Esmolol—Dizziness—Bupropion—obesity	5.95e-05	0.00104	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	5.93e-05	0.00104	CcSEcCtD
Esmolol—Oxprenolol—ADRB2—obesity	5.92e-05	0.0207	CrCbGaD
Esmolol—Dry mouth—Topiramate—obesity	5.84e-05	0.00102	CcSEcCtD
Esmolol—Confusional state—Topiramate—obesity	5.78e-05	0.00101	CcSEcCtD
Esmolol—Oedema—Topiramate—obesity	5.73e-05	0.001	CcSEcCtD
Esmolol—Vomiting—Bupropion—obesity	5.72e-05	0.000998	CcSEcCtD
Esmolol—Shock—Topiramate—obesity	5.64e-05	0.000984	CcSEcCtD
Esmolol—Headache—Bupropion—obesity	5.63e-05	0.000984	CcSEcCtD
Esmolol—Nervous system disorder—Topiramate—obesity	5.62e-05	0.000981	CcSEcCtD
Esmolol—Skin disorder—Topiramate—obesity	5.56e-05	0.000972	CcSEcCtD
Esmolol—Pindolol—ADRB1—obesity	5.54e-05	0.0194	CrCbGaD
Esmolol—Hyperhidrosis—Topiramate—obesity	5.54e-05	0.000967	CcSEcCtD
Esmolol—Anorexia—Topiramate—obesity	5.46e-05	0.000954	CcSEcCtD
Esmolol—Alprenolol—ADRB2—obesity	5.42e-05	0.019	CrCbGaD
Esmolol—Hypotension—Topiramate—obesity	5.35e-05	0.000935	CcSEcCtD
Esmolol—Nausea—Bupropion—obesity	5.34e-05	0.000933	CcSEcCtD
Esmolol—Paraesthesia—Topiramate—obesity	5.14e-05	0.000898	CcSEcCtD
Esmolol—Dyspnoea—Topiramate—obesity	5.11e-05	0.000892	CcSEcCtD
Esmolol—Somnolence—Topiramate—obesity	5.09e-05	0.000889	CcSEcCtD
Esmolol—Dyspepsia—Topiramate—obesity	5.04e-05	0.000881	CcSEcCtD
Esmolol—Metoprolol—ADRB2—obesity	5.04e-05	0.0176	CrCbGaD
Esmolol—Decreased appetite—Topiramate—obesity	4.98e-05	0.00087	CcSEcCtD
Esmolol—Gastrointestinal disorder—Topiramate—obesity	4.95e-05	0.000864	CcSEcCtD
Esmolol—Fatigue—Topiramate—obesity	4.94e-05	0.000862	CcSEcCtD
Esmolol—Constipation—Topiramate—obesity	4.9e-05	0.000855	CcSEcCtD
Esmolol—Pain—Topiramate—obesity	4.9e-05	0.000855	CcSEcCtD
Esmolol—Feeling abnormal—Topiramate—obesity	4.72e-05	0.000824	CcSEcCtD
Esmolol—Pindolol—ADRB2—obesity	4.66e-05	0.0163	CrCbGaD
Esmolol—Urticaria—Topiramate—obesity	4.55e-05	0.000795	CcSEcCtD
Esmolol—Body temperature increased—Topiramate—obesity	4.53e-05	0.000791	CcSEcCtD
Esmolol—Propafenone—ADRB1—obesity	4.42e-05	0.0154	CrCbGaD
Esmolol—Asthenia—Topiramate—obesity	4.11e-05	0.000718	CcSEcCtD
Esmolol—Pruritus—Topiramate—obesity	4.05e-05	0.000708	CcSEcCtD
Esmolol—Dizziness—Topiramate—obesity	3.79e-05	0.000661	CcSEcCtD
Esmolol—Ibuprofen—PPARG—obesity	3.66e-05	0.0128	CrCbGaD
Esmolol—Vomiting—Topiramate—obesity	3.64e-05	0.000636	CcSEcCtD
Esmolol—Headache—Topiramate—obesity	3.59e-05	0.000627	CcSEcCtD
Esmolol—Chlorphenesin—PTGS2—obesity	3.47e-05	0.0121	CrCbGaD
Esmolol—Propranolol—HTR1B—obesity	3.42e-05	0.012	CrCbGaD
Esmolol—Nausea—Topiramate—obesity	3.4e-05	0.000594	CcSEcCtD
Esmolol—Propranolol—ADRB1—obesity	3.02e-05	0.0106	CrCbGaD
Esmolol—Propranolol—ADRB2—obesity	2.54e-05	0.0089	CrCbGaD
Esmolol—Ibuprofen—PTGS2—obesity	1.55e-05	0.00541	CrCbGaD
Esmolol—Ibuprofen—ALB—obesity	1.38e-05	0.00482	CrCbGaD
Esmolol—ADRB2—Signaling by GPCR—DRD4—obesity	1.19e-05	0.000384	CbGpPWpGaD
Esmolol—ADRB2—GPCR ligand binding—CCL2—obesity	1.18e-05	0.000381	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—CNR1—obesity	1.16e-05	0.000374	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—CNR1—obesity	1.14e-05	0.000366	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—DRD2—obesity	1.13e-05	0.000365	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—GCG—obesity	1.12e-05	0.000362	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—ADRB2—obesity	1.12e-05	0.00036	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—ADRB3—obesity	1.11e-05	0.000358	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—DRD2—obesity	1.11e-05	0.000357	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—GCG—obesity	1.1e-05	0.000354	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—ADRB3—obesity	1.09e-05	0.00035	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—GAL—obesity	1.08e-05	0.00035	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—C5AR1—obesity	1.07e-05	0.000346	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—GNB3—obesity	1.06e-05	0.000343	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—GAL—obesity	1.06e-05	0.000342	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—C5AR1—obesity	1.05e-05	0.000338	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—GNB3—obesity	1.04e-05	0.000336	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—GNAS—obesity	1.04e-05	0.000334	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—ADRB2—obesity	1.02e-05	0.000327	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—GNAS—obesity	1.01e-05	0.000327	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—CCL5—obesity	9.91e-06	0.00032	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PRKG1—obesity	9.81e-06	0.000316	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CCK—obesity	9.81e-06	0.000316	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—CCL5—obesity	9.7e-06	0.000313	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—GNB3—obesity	9.67e-06	0.000312	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CCK—obesity	9.59e-06	0.000309	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PRKG1—obesity	9.59e-06	0.000309	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—RBP4—obesity	9.56e-06	0.000308	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—GLP1R—obesity	9.56e-06	0.000308	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—GNB3—obesity	9.46e-06	0.000305	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—GNAS—obesity	9.41e-06	0.000303	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CCKAR—obesity	9.4e-06	0.000303	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—HRH3—obesity	9.4e-06	0.000303	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—RBP4—obesity	9.35e-06	0.000301	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—GLP1R—obesity	9.35e-06	0.000301	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—GNAS—obesity	9.21e-06	0.000297	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—HRH3—obesity	9.2e-06	0.000297	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CCKAR—obesity	9.2e-06	0.000297	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PRKAR2B—obesity	9.05e-06	0.000292	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—CCL5—obesity	9e-06	0.00029	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—PRKCD—obesity	8.93e-06	0.000288	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PRKAR2B—obesity	8.85e-06	0.000285	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—CCL5—obesity	8.8e-06	0.000284	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—NCF2—obesity	8.74e-06	0.000282	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—HTR2A—obesity	8.74e-06	0.000282	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—PRKCD—obesity	8.73e-06	0.000282	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—C3—obesity	8.73e-06	0.000281	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—NCF2—obesity	8.55e-06	0.000276	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—HTR2A—obesity	8.55e-06	0.000276	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—C3—obesity	8.54e-06	0.000275	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—NPY—obesity	8.52e-06	0.000275	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—IAPP—obesity	8.47e-06	0.000273	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—APOC3—obesity	8.47e-06	0.000273	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—NPY—obesity	8.33e-06	0.000269	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—AGT—obesity	8.29e-06	0.000267	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—APOC3—obesity	8.28e-06	0.000267	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—IAPP—obesity	8.28e-06	0.000267	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CRH—obesity	8.22e-06	0.000265	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—HTR1B—obesity	8.22e-06	0.000265	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—SDC1—obesity	8.13e-06	0.000262	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—AGT—obesity	8.11e-06	0.000261	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—PRKCD—obesity	8.11e-06	0.000261	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—HTR1B—obesity	8.04e-06	0.000259	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CRH—obesity	8.04e-06	0.000259	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—AKR1C3—obesity	8e-06	0.000258	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—SDC1—obesity	7.95e-06	0.000256	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—HTR2A—obesity	7.94e-06	0.000256	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—PRKCD—obesity	7.93e-06	0.000256	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—C3—obesity	7.92e-06	0.000255	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—AKR1C3—obesity	7.82e-06	0.000252	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—NPS—obesity	7.79e-06	0.000251	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—HTR2A—obesity	7.76e-06	0.00025	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—C3—obesity	7.75e-06	0.00025	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—F2—obesity	7.66e-06	0.000247	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—PRKCB—obesity	7.66e-06	0.000247	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—DRD1—obesity	7.64e-06	0.000246	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—HTR2C—obesity	7.64e-06	0.000246	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—NPS—obesity	7.62e-06	0.000246	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—AGT—obesity	7.53e-06	0.000243	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—PRKCB—obesity	7.49e-06	0.000242	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—F2—obesity	7.49e-06	0.000242	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—DRD1—obesity	7.48e-06	0.000241	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—HTR2C—obesity	7.48e-06	0.000241	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—NTRK2—obesity	7.43e-06	0.00024	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—AGT—obesity	7.37e-06	0.000237	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—PIK3CG—obesity	7.33e-06	0.000236	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—NTRK2—obesity	7.27e-06	0.000234	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PARP1—obesity	7.24e-06	0.000234	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—GHRL—obesity	7.24e-06	0.000234	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—ADRB1—obesity	7.24e-06	0.000233	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—DRD4—obesity	7.18e-06	0.000232	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—PIK3CG—obesity	7.17e-06	0.000231	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PARP1—obesity	7.09e-06	0.000228	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—GHRL—obesity	7.09e-06	0.000228	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—DRD4—obesity	7.03e-06	0.000227	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—POMC—obesity	6.98e-06	0.000225	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—PRKCB—obesity	6.96e-06	0.000224	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—F2—obesity	6.96e-06	0.000224	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CNR1—obesity	6.86e-06	0.000221	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—POMC—obesity	6.83e-06	0.00022	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—PRKCB—obesity	6.81e-06	0.000219	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—F2—obesity	6.81e-06	0.000219	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—TCF7L2—obesity	6.74e-06	0.000217	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CNR1—obesity	6.71e-06	0.000216	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—AKT2—obesity	6.71e-06	0.000216	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—DRD2—obesity	6.69e-06	0.000216	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—PIK3CG—obesity	6.66e-06	0.000215	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—GCG—obesity	6.63e-06	0.000214	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PTPN1—obesity	6.63e-06	0.000214	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—TCF7L2—obesity	6.59e-06	0.000213	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—AKT2—obesity	6.56e-06	0.000212	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—DRD2—obesity	6.55e-06	0.000211	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—PIK3CG—obesity	6.51e-06	0.00021	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PTPN1—obesity	6.48e-06	0.000209	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—GCG—obesity	6.48e-06	0.000209	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—PIK3CD—obesity	6.45e-06	0.000208	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—POMC—obesity	6.34e-06	0.000204	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PRL—obesity	6.32e-06	0.000204	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—PIK3CD—obesity	6.3e-06	0.000203	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—STK11—obesity	6.23e-06	0.000201	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—CCL2—obesity	6.2e-06	0.0002	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—POMC—obesity	6.2e-06	0.0002	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PRL—obesity	6.18e-06	0.000199	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PLG—obesity	6.16e-06	0.000199	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—RHOA—obesity	6.15e-06	0.000198	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—STK11—obesity	6.09e-06	0.000196	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—AKT2—obesity	6.09e-06	0.000196	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—PIK3R1—obesity	6.09e-06	0.000196	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—CCL2—obesity	6.07e-06	0.000196	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PLG—obesity	6.03e-06	0.000194	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—RHOA—obesity	6.02e-06	0.000194	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—FOXO3—obesity	6.01e-06	0.000194	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—ADRB2—obesity	6e-06	0.000193	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—AKT2—obesity	5.96e-06	0.000192	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—PIK3R1—obesity	5.95e-06	0.000192	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—SOCS1—obesity	5.91e-06	0.00019	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—FOXO3—obesity	5.88e-06	0.00019	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—PIK3CD—obesity	5.85e-06	0.000189	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—SOCS3—obesity	5.83e-06	0.000188	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—SOCS1—obesity	5.78e-06	0.000186	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—PIK3CD—obesity	5.73e-06	0.000185	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—GNB3—obesity	5.71e-06	0.000184	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—SOCS3—obesity	5.71e-06	0.000184	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—TYK2—obesity	5.63e-06	0.000182	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—PIK3CB—obesity	5.62e-06	0.000181	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—IGF2—obesity	5.61e-06	0.000181	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—GNB3—obesity	5.59e-06	0.00018	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—RHOA—obesity	5.58e-06	0.00018	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—GNAS—obesity	5.56e-06	0.000179	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—PIK3R1—obesity	5.53e-06	0.000178	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—TYK2—obesity	5.51e-06	0.000178	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—PIK3CB—obesity	5.5e-06	0.000177	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—IGF2—obesity	5.49e-06	0.000177	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—RHOA—obesity	5.46e-06	0.000176	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—APOB—obesity	5.44e-06	0.000176	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—GNAS—obesity	5.44e-06	0.000175	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—PIK3R1—obesity	5.41e-06	0.000174	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—APOB—obesity	5.33e-06	0.000172	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CCL5—obesity	5.32e-06	0.000171	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CCL5—obesity	5.2e-06	0.000168	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—LPL—obesity	5.2e-06	0.000168	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—FOXO1—obesity	5.16e-06	0.000166	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—RPS6KB1—obesity	5.15e-06	0.000166	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—PIK3CB—obesity	5.1e-06	0.000164	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—LPL—obesity	5.09e-06	0.000164	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—FOXO1—obesity	5.05e-06	0.000163	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—RPS6KB1—obesity	5.04e-06	0.000163	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—PIK3CB—obesity	4.99e-06	0.000161	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PRKCD—obesity	4.79e-06	0.000154	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—HTR2A—obesity	4.69e-06	0.000151	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PRKCD—obesity	4.69e-06	0.000151	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—C3—obesity	4.68e-06	0.000151	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—HTR2A—obesity	4.59e-06	0.000148	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—C3—obesity	4.58e-06	0.000148	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—IRS2—obesity	4.45e-06	0.000144	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—AGT—obesity	4.45e-06	0.000143	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—APOE—obesity	4.36e-06	0.000141	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—LEP—obesity	4.36e-06	0.000141	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—IRS2—obesity	4.36e-06	0.00014	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—AGT—obesity	4.35e-06	0.00014	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CAV1—obesity	4.32e-06	0.000139	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—APOA1—obesity	4.31e-06	0.000139	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—LEP—obesity	4.26e-06	0.000137	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—APOE—obesity	4.26e-06	0.000137	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CAV1—obesity	4.22e-06	0.000136	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—APOA1—obesity	4.21e-06	0.000136	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—ESR1—obesity	4.16e-06	0.000134	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PRKCB—obesity	4.11e-06	0.000133	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—F2—obesity	4.11e-06	0.000133	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—ESR1—obesity	4.07e-06	0.000131	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—BAD—obesity	4.06e-06	0.000131	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—F2—obesity	4.02e-06	0.00013	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PRKCB—obesity	4.02e-06	0.00013	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—BAD—obesity	3.97e-06	0.000128	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PIK3CG—obesity	3.93e-06	0.000127	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—IRS1—obesity	3.89e-06	0.000125	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PIK3CG—obesity	3.85e-06	0.000124	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—IRS1—obesity	3.8e-06	0.000123	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—POMC—obesity	3.74e-06	0.000121	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—INS—obesity	3.72e-06	0.00012	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CCL2—obesity	3.66e-06	0.000118	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—POMC—obesity	3.66e-06	0.000118	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—INS—obesity	3.64e-06	0.000117	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—IGF1—obesity	3.6e-06	0.000116	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—AKT2—obesity	3.6e-06	0.000116	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CCL2—obesity	3.58e-06	0.000116	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—IGF1—obesity	3.52e-06	0.000114	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—AKT2—obesity	3.52e-06	0.000113	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PIK3CD—obesity	3.46e-06	0.000111	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—PIK3CA—obesity	3.42e-06	0.00011	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—SERPINE1—obesity	3.42e-06	0.00011	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PIK3CD—obesity	3.38e-06	0.000109	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—PIK3CA—obesity	3.35e-06	0.000108	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—SERPINE1—obesity	3.35e-06	0.000108	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—TYK2—obesity	3.33e-06	0.000107	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—RHOA—obesity	3.3e-06	0.000106	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PIK3R1—obesity	3.26e-06	0.000105	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—NOS3—obesity	3.26e-06	0.000105	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—TYK2—obesity	3.25e-06	0.000105	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—RHOA—obesity	3.23e-06	0.000104	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—NOS3—obesity	3.19e-06	0.000103	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PIK3R1—obesity	3.19e-06	0.000103	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—PIK3CA—obesity	3.11e-06	0.0001	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—PIK3CA—obesity	3.04e-06	9.81e-05	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PIK3CB—obesity	3.01e-06	9.72e-05	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—MTOR—obesity	3.01e-06	9.72e-05	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PIK3CB—obesity	2.95e-06	9.5e-05	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—MTOR—obesity	2.95e-06	9.5e-05	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—AKT1—obesity	2.8e-06	9.02e-05	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—IL6—obesity	2.75e-06	8.88e-05	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—AKT1—obesity	2.74e-06	8.82e-05	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—IL6—obesity	2.69e-06	8.69e-05	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—MMP9—obesity	2.62e-06	8.45e-05	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—MMP9—obesity	2.56e-06	8.26e-05	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—MAPK8—obesity	2.55e-06	8.21e-05	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—AKT1—obesity	2.54e-06	8.19e-05	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—MAPK8—obesity	2.49e-06	8.03e-05	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—AKT1—obesity	2.49e-06	8.01e-05	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—STAT3—obesity	2.33e-06	7.51e-05	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—STAT3—obesity	2.28e-06	7.35e-05	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—MYC—obesity	2.16e-06	6.98e-05	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—TGFB1—obesity	2.16e-06	6.96e-05	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—MYC—obesity	2.12e-06	6.83e-05	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—TGFB1—obesity	2.11e-06	6.81e-05	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PIK3CA—obesity	1.84e-06	5.92e-05	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PIK3CA—obesity	1.8e-06	5.79e-05	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—IL6—obesity	1.63e-06	5.24e-05	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—IL6—obesity	1.59e-06	5.13e-05	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—AKT1—obesity	1.5e-06	4.84e-05	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—AKT1—obesity	1.47e-06	4.73e-05	CbGpPWpGaD
